These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 21874797)
1. [Parameters related to fibrinolysis and their meanings]. Urano T; Suzuki Y Rinsho Byori; 2011 Jul; 59(7):703-8. PubMed ID: 21874797 [TBL] [Abstract][Full Text] [Related]
2. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462 [TBL] [Abstract][Full Text] [Related]
3. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism]. Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724 [TBL] [Abstract][Full Text] [Related]
4. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction. Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093 [TBL] [Abstract][Full Text] [Related]
5. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
6. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions. Wu JH; Diamond SL Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011 [TBL] [Abstract][Full Text] [Related]
7. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation. Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964 [TBL] [Abstract][Full Text] [Related]
8. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA. Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502 [TBL] [Abstract][Full Text] [Related]
9. The impact of the fibrinolytic system on the risk of venous and arterial thrombosis. Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T Semin Thromb Hemost; 2009 Jul; 35(5):468-77. PubMed ID: 19739037 [TBL] [Abstract][Full Text] [Related]
10. Quantification of the effects of thrombin activatable fibrinolysis inhibitor and alpha2-antiplasmin on fibrinolysis in normal human plasma. Nielsen VG; Ellis TC Blood Coagul Fibrinolysis; 2007 Jan; 18(1):29-33. PubMed ID: 17179823 [TBL] [Abstract][Full Text] [Related]
11. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases. Collatos C; Barton MH; Prasse KW; Moore JN J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947 [TBL] [Abstract][Full Text] [Related]
12. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [TBL] [Abstract][Full Text] [Related]
13. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation. Hare TR; Gardell SJ Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162 [TBL] [Abstract][Full Text] [Related]
14. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model. Guimarães AH; Rijken DC Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222 [TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis system in patients with bronchial asthma. Banach-Wawrzeńczyk E; Dziedziczko A; Rość D Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294 [TBL] [Abstract][Full Text] [Related]
16. A history of early stent thrombosis is associated with prolonged clot lysis time. Pankiw-Bembenek O; Zalewski J; Goralczyk T; Undas A Thromb Haemost; 2012 Mar; 107(3):513-20. PubMed ID: 22274545 [TBL] [Abstract][Full Text] [Related]
17. The influence of age on in vitro plasmin generation in the presence of fibrin monomer. Parmar N; Mitchell LG; Berry LR; Andrew M; Chan AK Acta Haematol; 2006; 115(3-4):141-51. PubMed ID: 16549888 [TBL] [Abstract][Full Text] [Related]
18. A new euglobulin clot lysis assay for global fibrinolysis. Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279 [TBL] [Abstract][Full Text] [Related]
19. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation. Singh S; Houng A; Reed GL Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples. Lewis MR; Callas PW; Jenny NS; Tracy RP Thromb Haemost; 2001 Dec; 86(6):1495-500. PubMed ID: 11776319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]